Logo image of BLV.PA

BELIEVE SA (BLV.PA) Stock Fundamental Analysis

EPA:BLV - Euronext Paris - Matif - FR0014003FE9 - Common Stock - Currency: EUR

17.12  +0.04 (+0.23%)

Fundamental Rating

2

Taking everything into account, BLV scores 2 out of 10 in our fundamental rating. BLV was compared to 44 industry peers in the Entertainment industry. BLV may be in some trouble as it scores bad on both profitability and health. BLV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BLV has reported negative net income.
In the past year BLV had a positive cash flow from operations.
BLV had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BLV reported negative operating cash flow in multiple years.
BLV.PA Yearly Net Income VS EBIT VS OCF VS FCFBLV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

BLV has a Return On Assets of -0.26%. This is comparable to the rest of the industry: BLV outperforms 54.55% of its industry peers.
Looking at the Return On Equity, with a value of -0.85%, BLV is in line with its industry, outperforming 56.82% of the companies in the same industry.
Industry RankSector Rank
ROA -0.26%
ROE -0.85%
ROIC N/A
ROA(3y)-1.24%
ROA(5y)-2.22%
ROE(3y)-3.42%
ROE(5y)-7.25%
ROIC(3y)N/A
ROIC(5y)N/A
BLV.PA Yearly ROA, ROE, ROICBLV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

BLV's Gross Margin of 33.70% is on the low side compared to the rest of the industry. BLV is outperformed by 72.73% of its industry peers.
BLV's Gross Margin has been stable in the last couple of years.
BLV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-1.4%
BLV.PA Yearly Profit, Operating, Gross MarginsBLV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

BLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLV has more shares outstanding
Compared to 5 years ago, BLV has more shares outstanding
BLV has a worse debt/assets ratio than last year.
BLV.PA Yearly Shares OutstandingBLV.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLV.PA Yearly Total Debt VS Total AssetsBLV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that BLV is in the distress zone and has some risk of bankruptcy.
BLV has a Altman-Z score of 1.78. This is in the better half of the industry: BLV outperforms 72.73% of its industry peers.
BLV has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.08, BLV is doing good in the industry, outperforming 79.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC7.85%
BLV.PA Yearly LT Debt VS Equity VS FCFBLV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.71 indicates that BLV may have some problems paying its short term obligations.
With a Current ratio value of 0.71, BLV perfoms like the industry average, outperforming 43.18% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that BLV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, BLV is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.7
BLV.PA Yearly Current Assets VS Current LiabilitesBLV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.83% over the past year.
BLV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.33%.
The Revenue has been growing by 20.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)66.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.5%
Revenue 1Y (TTM)12.33%
Revenue growth 3Y19.66%
Revenue growth 5Y20.17%
Sales Q2Q%105.96%

3.2 Future

Based on estimates for the next years, BLV will show a very strong growth in Earnings Per Share. The EPS will grow by 201.70% on average per year.
The Revenue is expected to grow by 14.14% on average over the next years. This is quite good.
EPS Next Y2350%
EPS Next 2Y536.4%
EPS Next 3Y289.3%
EPS Next 5Y201.7%
Revenue Next Year14.51%
Revenue Next 2Y13.63%
Revenue Next 3Y14.55%
Revenue Next 5Y14.14%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLV.PA Yearly Revenue VS EstimatesBLV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLV.PA Yearly EPS VS EstimatesBLV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLV. In the last year negative earnings were reported.
BLV is valuated quite expensively with a Price/Forward Earnings ratio of 75.34.
The rest of the industry has a similar Price/Forward Earnings ratio as BLV.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, BLV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 75.34
BLV.PA Price Earnings VS Forward Price EarningsBLV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLV indicates a slightly more expensive valuation: BLV is more expensive than 63.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.3
BLV.PA Per share dataBLV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLV's earnings are expected to grow with 289.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y536.4%
EPS Next 3Y289.3%

More info and screens

0

5. Dividend

5.1 Amount

BLV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELIEVE SA

EPA:BLV (6/18/2025, 7:00:00 PM)

17.12

+0.04 (+0.23%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)07-31 2025-07-31
Inst Owners1.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.72B
Analysts74.29
Price Target16.22 (-5.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)15.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 75.34
P/S 1.74
P/FCF N/A
P/OCF 78.61
P/B 4.8
P/tB 26.57
EV/EBITDA 32.3
EPS(TTM)-0.02
EYN/A
EPS(NY)0.23
Fwd EY1.33%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.22
OCFY1.27%
SpS9.82
BVpS3.57
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.26%
ROE -0.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.7%
FCFM N/A
ROA(3y)-1.24%
ROA(5y)-2.22%
ROE(3y)-3.42%
ROE(5y)-7.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-1.4%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.59
Cap/Depr 82.57%
Cap/Sales 4.21%
Interest Coverage N/A
Cash Conversion 43.83%
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.7
Altman-Z 1.78
F-Score5
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)74.51%
Cap/Depr(5y)88.63%
Cap/Sales(3y)4.46%
Cap/Sales(5y)5.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.5%
EPS Next Y2350%
EPS Next 2Y536.4%
EPS Next 3Y289.3%
EPS Next 5Y201.7%
Revenue 1Y (TTM)12.33%
Revenue growth 3Y19.66%
Revenue growth 5Y20.17%
Sales Q2Q%105.96%
Revenue Next Year14.51%
Revenue Next 2Y13.63%
Revenue Next 3Y14.55%
Revenue Next 5Y14.14%
EBIT growth 1Y98.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5800%
EBIT Next 3Y355.76%
EBIT Next 5Y232.65%
FCF growth 1Y47.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.57%
OCF growth 3YN/A
OCF growth 5Y-7.19%